These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 12072778

  • 1. Tc-99m sestamibi bone marrow scintigraphy in Gaucher disease.
    Aharoni D, Krausz Y, Elstein D, Hadas-Halpern I, Zimran A.
    Clin Nucl Med; 2002 Jul; 27(7):503-9. PubMed ID: 12072778
    [Abstract] [Full Text] [Related]

  • 2. Severity of bone marrow involvement in patients with Gaucher's disease evaluated by scintigraphy with 99mTc-sestamibi.
    Mariani G, Filocamo M, Giona F, Villa G, Amendola A, Erba P, Buffoni F, Copello F, Pierini A, Minichilli F, Gatti R, Brady RO.
    J Nucl Med; 2003 Aug; 44(8):1253-62. PubMed ID: 12902415
    [Abstract] [Full Text] [Related]

  • 3. Different patterns of technetium-99m sestamibi uptake in multiple myeloma.
    Pace L, Catalano L, Pinto A, De Renzo A, Di Gennaro F, Califano C, Del Vecchio S, Rotoli B, Salvatore M.
    Eur J Nucl Med; 1998 Jul; 25(7):714-20. PubMed ID: 9662593
    [Abstract] [Full Text] [Related]

  • 4. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
    Erten N, Saka B, Berberoglu K, Turkmen C, Unal S, Bakir B, Yekeler E, Besisik SK.
    Ann Hematol; 2007 Nov; 86(11):805-13. PubMed ID: 17684742
    [Abstract] [Full Text] [Related]

  • 5. Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma.
    Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Di Gennaro F, Catalano L, Califano C, Pace L, Rotoli B, Salvatore M.
    Eur J Nucl Med; 2001 Feb; 28(2):214-20. PubMed ID: 11303893
    [Abstract] [Full Text] [Related]

  • 6. Scintigraphic findings on 99mTc-MDP, 99mTc-sestamibi and 99mTc-HMPAO images in Gaucher's disease.
    Mariani G, Molea N, La Civita L, Porciello G, Lazzeri E, Ferri C.
    Eur J Nucl Med; 1996 Apr; 23(4):466-70. PubMed ID: 8612670
    [Abstract] [Full Text] [Related]

  • 7. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
    Balleari E, Villa G, Garrè S, Ghirlanda P, Agnese G, Carletto M, Clavio M, Ferrando F, Gobbi M, Mariani G, Ghio R.
    Haematologica; 2001 Jan; 86(1):78-84. PubMed ID: 11146575
    [Abstract] [Full Text] [Related]

  • 8. Scintigraphic evaluation of Tc-99m-low-density lipoprotein (LDL) distribution in patients with Gaucher disease.
    Lorberboym M, Vallabhajosula S, Lipszyc H, Pastores G.
    Clin Genet; 1997 Jul; 52(1):7-11. PubMed ID: 9272706
    [Abstract] [Full Text] [Related]

  • 9. Is there a role for scintigraphic imaging of bone manifestations in Gaucher disease? A review of the literature.
    Mikosch P, Kohlfürst S, Gallowitsch HJ, Kresnik E, Lind P, Mehta AB, Hughes DA.
    Nuklearmedizin; 2008 Jul; 47(6):239-47. PubMed ID: 19057797
    [Abstract] [Full Text] [Related]

  • 10. 99mTc-sestamibi scintigraphy to monitor the long-term efficacy of enzyme replacement therapy on bone marrow infiltration in patients with Gaucher disease.
    Erba PA, Minichilli F, Giona F, Linari S, Dambrosia J, Pierini A, Filocamo M, Di Rocco M, Buffoni F, Brady RO, Mariani G.
    J Nucl Med; 2013 Oct; 54(10):1717-24. PubMed ID: 23990684
    [Abstract] [Full Text] [Related]

  • 11. 99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy.
    Alper E, Gurel M, Evrensel T, Ozkocaman V, Akbunar T, Demiray M.
    Nucl Med Commun; 2003 May; 24(5):537-42. PubMed ID: 12717071
    [Abstract] [Full Text] [Related]

  • 12. Bone, bone marrow, and MIBI scintigraphic findings in Gaucher's disease "bone crisis".
    Blocklet D, Abramowicz M, Schoutens A.
    Clin Nucl Med; 2001 Sep; 26(9):765-9. PubMed ID: 11507294
    [Abstract] [Full Text] [Related]

  • 13. Bone uptake of Tc-99m MIBI in patients with hyperparathyroidism.
    Zhao Y, Wang Q.
    Ann Nucl Med; 2014 May; 28(4):349-55. PubMed ID: 24519437
    [Abstract] [Full Text] [Related]

  • 14. Tc-99m methoxyisobutylisonitrile bone marrow imaging for predicting the levels of myeloma cells in bone marrow in multiple myeloma: correlation with CD38/CD138 expressing myeloma cells.
    Ak I, Aslan V, Vardareli E, Gülbaş Z.
    Ann Hematol; 2003 Feb; 82(2):88-92. PubMed ID: 12601486
    [Abstract] [Full Text] [Related]

  • 15. Assessment of the P-glycoprotein expression by 99mTc-MIBI bone marrow imaging in patients with untreated leukaemia.
    Ak I, Aslan V, Vardareli E, Gülbaş Z.
    Nucl Med Commun; 2003 Apr; 24(4):397-402. PubMed ID: 12673168
    [Abstract] [Full Text] [Related]

  • 16. Use of various diagnostic methods in a patient with Gaucher disease type I.
    Farahati J, Trenn G, John-Mikolajewski V, Zander C, Pastores GM, Sciuk J, Reiners C.
    Clin Nucl Med; 1996 Aug; 21(8):619-25. PubMed ID: 8853914
    [Abstract] [Full Text] [Related]

  • 17. The prognostic value of F-18 fluorodeoxyglucose bone marrow uptake in patients with recent diagnosis of multiple myeloma: a comparative study with Tc-99m sestamibi.
    Castellani M, Carletto M, Baldini L, Calori R, Longari V, Soligo D, Dellavedova L, Gerundini P.
    Clin Nucl Med; 2010 Jan; 35(1):1-5. PubMed ID: 20026963
    [Abstract] [Full Text] [Related]

  • 18. Scintigraphic monitoring of reticuloendothelial system in patients with type 1 Gaucher disease on enzyme replacement therapy.
    Lorberboym M, Pastores GM, Kim CK, Hermann G, Glajchen N, Machac J.
    J Nucl Med; 1997 Jun; 38(6):890-5. PubMed ID: 9189137
    [Abstract] [Full Text] [Related]

  • 19. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
    Iwata M, Kasagi K, Misaki T, Matsumoto K, Iida Y, Ishimori T, Nakamoto Y, Higashi T, Saga T, Konishi J.
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
    [Abstract] [Full Text] [Related]

  • 20. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities.
    Moustafa H, Riad R, Omar W, Zaher A, Ebied E.
    Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.